This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this interview, Kleinman explores critical issues facing modern healthcare. Listen to the audio of the interview here. The middle class has come to understand genetics, biotechnology, and pharmaceuticals and is better educated in science and technology. See prior interview with Mad in America.)
He maintains an active program of research in the pharmacoepidemiology of controlled substances including opioids, cannabinoids, and other controlled substances, behavioral neurology methods development and quantitative medical ethics. Listen to the audio of the interview here. James Moore: Lisa and Brian, welcome both of you.
I n this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. Listen to the audio of the interview here. Who’s Maudsley?
Listen to the audio of the interview here. Once those are under control, they can get still, slow down, and have an inner conversation to uncover the true anxiety at the heart of it all. We have so much control over how our genetic predispositions manifest. The transcript below has been edited for length and clarity.
published an article online with interviews of professionals about their experiences of working with the implementation of the Norwegian action plans and guidelines for suicide prevention. [9] 18] Goldney had received “gold” “from a number of pharmaceutical companies.” It was exceedingly difficult for Hjelmeland et al.
In this interview, we talk about her experiences of withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects , published in 2022 which is one of the first books on antidepressant withdrawal to make it to the mass market. Listen to the audio of the interview here. James Moore: Brooke, welcome.
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here. Moore: The last couple of questions are related to the pharmaceutical industry. Why is it threatened?
I surprised myself at how much I enjoyed the experience of interviewing these interesting patients. I had to learn to recognise my survival persona, one who was easily controlled and coerced. At last, I started to process memories and emotions that had remained suppressed for decades.
So well that no Randomized Controlled Trials (RCTs) were needed to show they worked. They might be randomizing, and controlling with a placebo, but they were doing Assays—Randomized Controlled Assays (RCAs). Standardizing clinical interviews risks disaster. Who said no RCTs were needed? What’s an Assay? And they don’t.
To not sell yourself short, you have to know your priorities going into an interview or conversation with your boss. Create your own boundaries from the start Gina Newton, a pharmaceutical consultant-turned-spiritual lifestyle coach, sets clear boundaries with clients up front.
For example, they might say, “We’re a bank,” or “We make office furniture,” or “We’re in the pharmaceutical business.” As he put it in an interview in 2014, “I always thought it was kind of stupid if you have this big company, and you can only do, like, five things.” This is quite understandable.
I decided to turn my professional eye on BetterHelp, the largest and most prominent of these services, seeking my own psychotherapy with the company, applying and getting hired as a therapist, and interviewing BetterHelp clinicians. For me, it’s quality control,” Wampold said. “Is The background check was completed quickly.
You sent some great questions and on this and our next podcast, we will be talking with Bob about Mad in America, the biopsychosocial model, the history of psychiatry, pharmaceutical marketing, and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Listen to the audio of the interview here.
That was just a lot less salient abroad,” she pointed out in an interview. For years, the 40-year-old from India’s Panipat lived in fear—she was convinced that a spirit had taken control of her. While his sons eventually recovered, he and his wife remained under the spirit’s control. The spirit talks to us, makes fun of us.
Characteristics typically include: Qualities that make for costly medication delivery, such as requirements for professional administration or special handling e.g., temperature control. Does your PBM require providers to use NDC coding for Specialty Pharmaceuticals to improve monitoring and tracking of utilization? ASHA uses $1,000.
His Get Attitude podcast won a Communicator Award for Diversity & Inclusion for his 8:46 Interviews Stories of Black America. As a keynote speaker, she has shared the stage with many influencers, including a recent interview with Venus Williams. Candy Valentino. Entrepreneur, CEO, founder.
” This interview was conducted by email. He also sent me to colleagues who had special knowledge of specific areas such as having a control group who did not have the rehab program, as well as scales and schedules to use in interviews, and which statistics to use. We began interviewing in 1980.
In this interview, Cartwright charts her journey of painful and lonely disillusionment with the “mental illness” framework. In this brutally honest book and interview, Cartwright reflects on the importance of holding all our understandings around mental health and suffering, lightly. Listen to the audio of the interview here.
Before we begin, I’d like to take a few moments and explain the context of this interview. Third, his journal told of the corrupting influence of pharmaceutical money on the creation of psychiatric diagnoses and drug trials. Listen to the audio of the interview here. W elcome to Mad In America Radio.
Given the dearth of controlled data (in real-world patients groups), results should have substantial public health and scientific significance, since they are obtained in representative participant groups/settings, using clinical management tools that can easily be applied in daily practice, the STAR*D investigators wrote.
The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.
That’s been the question posed to me in 2023 by interviewers such as Nick Fortino on “ Psychology Is ” and Mollie Adler on “Back from the Borderline. ” The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.
Listen to the audio of the interview here. I encourage everyone to read itit gives a powerful overview of how quickly things spiraled out of control. They interviewed us for four hours and brought the two main doctors up on charges. My name is Brooke Siem, and Im the author of May Cause Side Effects. He never practiced again.
Listen to the audio of the interview here. Thats not a leap people often makefrom philosophical psychology to critiques of the pharmaceutical industry and medicalization. She was deeply involved in critical psychiatry and critiques of the pharmaceutical industry. The transcript below has been edited for length and clarity.
In this interview, he explores the philosophical foundations of psychology, the psychological costs of neoliberalism, and why developing a critical psychology of education and mental health is more urgent than ever. Listen to the audio of the interview here. The supposed freedom of choice conceals deeper forms of control.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content